Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGIN

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Revealed
India's Third Giant Leap

This Could be One of the Biggest Opportunities for Investors




Important: We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
By submitting your email address, you also sign up for Profit Hunter, a daily newsletter from Equitymaster
covering exciting investing ideas and opportunities in India.

AD

Key indices shed some gains
Mon, 21 Jan 01:30 pm

Indian equity markets continued to trade in the positive territory, albeit in a range bound manner during the post noon trading session. Sectoral Indices are trading mixed with those from the oil and gas and FMCG spaces registering gains while realty and auto stocks traded weak.

BSE-Sensex is up by 28 points and NSE-Nifty is trading up by 3 points. While BSE Mid Cap is trading down by 0.14%, BSE Small Cap index is trading up by 0.09%. The rupee is trading at 53.89 to the US dollar.

Most of the Pharma stocks are trading in green with Dishman and Panacea Biotech being among the top gainers. Aurobindo Pharma announced, that it has received USFDA approval for Oxacillin injections packaged in 1g and 2g vials and 10g/vial Pharmacy bulk package. Currently there few generic companies selling Oxacillin based vials in US. This signifies company will have lower competition for this drug. As per the management the current market size for 1g and 2g vials is US$ 15.2 m and for 10g/Vial (Pharmacy Bulk Package)is US$13.5 m. The drug will be marketed by Aurobindo's subsidiary AuroMedics, this subsidiary largely responsible for generic injectable pharmaceutical Products in US. With this approval Aurobindo now has a total of 174 approvals from USFDA. The stock was trading up by 1.30%

Majority of the power stocks are trading in green with JSW Energy and Reliance Infra being the biggest gainers. As per a leading financial daily, Tata Power has said that that there no tangible business opportunities in the country and it is actively pursuing overseas opportunities in Africa, Middle East, Turkey and South East Asia. Tata Power currently has an installed generation capacity of 6,899 MW and is building a 4,000 MW ultra mega power project fired by imported coal at Mundra in Gujarat. Among projects in backlog are Maithon (Maharashtra), Mundra (Gujarat), Mandakani coal mine project in Orissa and coal mines in Jharkhand. These projects have been put on hold due to delay in clearances and fuel shortage. On the international front, the company has prioritized seven countries that includes South Africa and other Sub-Saharan African countries, Indonesia, Vietnam, Turkey and Middle East for implementation of projects in the power generation space. Tata Power expects to have a generation capacity of 26,000 MW by 2020. The stock is currently down 0.8%.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

View all commentaries | Archives

Read the latest Market Commentary


Equitymaster requests your view! Post a comment on "Key indices shed some gains". Click here!

  
ABOUT EQUITYMASTER

Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.

PREMIUM PRODUCTS
QUICK LINKS
POPULAR TOPICS
TRENDING TOPICS
FREE NEWSLETTERS
EQUITYMASTER SUPPORTS
  • HelpYourNGO
  • You Tube
  • Linkedin
  • Twitter
  • Telegram
  • Google Play

Copyright © Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited).

Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap

Phone +91-9136015013

Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited) (Research Analyst)
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Email: info@equitymaster.com. Website: www.equitymaster.com.
CIN:U74999MH2007PTC175407

Name of the Compliance & Grievance Officer: Ms Sonal Ramachandran
Telephone: +91-22-61434003 | Email: compliance@equitymaster.com

LEGAL DISCLAIMER:
Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited) (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.